PSAMP
JSPRW

P. Schoenfeld Asset Management (PSAM)’s Japer Therapeutics Warrants JSPRW Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-237,499
Closed -$273K – 369
2021
Q2 		$273K Hold
237,499
– – 0.02% 274
2021
Q1 		$195K Hold
237,499
– – 0.01% 280
2020
Q4 		$344K Hold
237,499
– – 0.03% 140
2020
Q3 		$280K Buy
+237,499
New +$240K 0.03% 97

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s JSPRW Position: Q3 2021 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2021, closing a stake of 237,499 shares — an estimated $273K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in JSPRW in Q3 2020 and held it in 4 quarters. The position peaked at $344K in Q4 2020. 16 funds tracked by Wall St. Rank hold JSPRW as of Q3 2021.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Japer Therapeutics Warrants position as of Q3 2021 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 237,499 Japer Therapeutics Warrants shares in Q3 2021, an estimated $273K.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 4 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Japer Therapeutics Warrants position peaked at $344K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2021.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q3 2021, filed 15 Nov 2021.